DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Green AGJCB. et al.
Positive phase II double-blind randomized placebo-controlled crossover trial of clemastine fumarate for remyelination of chronic optic neuropathy in MS.
Annual Meeting of the American Academy of Neurology.
Vancouver, BC, Canada: 2016 abstr ES1008
Access:
We do not assume any responsibility for the contents of the web pages of other providers.